FiercePharma | Nachrichten

Zeit	Aktuelle Nachrichten
Fr	Bristol-Myers Squibb's Opdivo secures a lung cancer niche with small-cell green light
Fr	Days after FDA rejection, Regeneron wins label expansion for Eylea
Fr	Trump urges Justice Department to target opioid makers with a 'major lawsuit'
Fr	FiercePharmaAsia-China's drug leader crackdown; Astellas' gene therapy deal; Huahai's problems
Fr	Eisai, Merck take on Bayer's Nexavar with new liver cancer nod for Lenvima
Fr	Teva wins FDA nod for its generic of Mylan's EpiPen after 2-year delay
Do	Louisiana seeking comments on 'Netflix' model for hepatitis C drugs
Do	Analyst chastises Mylan-not known for its transparency-for under-the-radar dealmaking
Do	Former China FDA chief to resign over the country's latest vaccine scandal
Do	Believer Buffett boosts his Teva stake as turnaround plan yields results
Do	Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case
Do	GlaxoSmithKline whacks 165 jobs as it closes skincare products plant in Ireland
Do	Apotex plant in India hit with third warning letter in 4 years
Mi	Thyroid drugs made with ingredient from banned Chinese plant recalled in U.S.
Mi	As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California
Mi	As EpiPens run short, Kaléo boasts it has an available supply of epinephrine injectors
Mi	GlaxoSmithKline scores new win for 2-drug HIV regimen, this time in long-acting version
Mi	Court tosses kickbacks case against Eli Lilly but allows plaintiffs another chance
Mi	Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change
Mi	'Ask your doctor' pitches from digital ads work almost as well as ones on TV: study
Di	News of Note-GeoVax, Inovio, BiondVax and more
Di	AIDS health group brings Gilead patent skirmish to Supreme Court
Di	Pfizer joins DOJ probe into claims pharma bribes funded Iraqi terrorists
Di	Allergan taps Pfizer oncology veteran as CMO for some crucial pipeline help
Di	Reeling from Cohen scandal, Novartis recruits Siemens veteran as new ethics chief

Zeit

Aktuelle Nachrichten

Bristol-Myers Squibb's Opdivo secures a lung cancer niche with small-cell green light

Days after FDA rejection, Regeneron wins label expansion for Eylea

Trump urges Justice Department to target opioid makers with a 'major lawsuit'

FiercePharmaAsia-China's drug leader crackdown; Astellas' gene therapy deal; Huahai's problems

Eisai, Merck take on Bayer's Nexavar with new liver cancer nod for Lenvima

Teva wins FDA nod for its generic of Mylan's EpiPen after 2-year delay

Louisiana seeking comments on 'Netflix' model for hepatitis C drugs

Analyst chastises Mylan-not known for its transparency-for under-the-radar dealmaking

Former China FDA chief to resign over the country's latest vaccine scandal

Believer Buffett boosts his Teva stake as turnaround plan yields results

Teva scoffs at whistleblowers' evidence in bid to dismiss kickbacks case

GlaxoSmithKline whacks 165 jobs as it closes skincare products plant in Ireland

Apotex plant in India hit with third warning letter in 4 years

Thyroid drugs made with ingredient from banned Chinese plant recalled in U.S.

As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California

As EpiPens run short, Kaléo boasts it has an available supply of epinephrine injectors

GlaxoSmithKline scores new win for 2-drug HIV regimen, this time in long-acting version

Court tosses kickbacks case against Eli Lilly but allows plaintiffs another chance

Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change

'Ask your doctor' pitches from digital ads work almost as well as ones on TV: study

News of Note-GeoVax, Inovio, BiondVax and more

AIDS health group brings Gilead patent skirmish to Supreme Court

Pfizer joins DOJ probe into claims pharma bribes funded Iraqi terrorists

Allergan taps Pfizer oncology veteran as CMO for some crucial pipeline help

Reeling from Cohen scandal, Novartis recruits Siemens veteran as new ethics chief

Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und mit der Push-Technologie von

Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage

Xetra-Orderbuch

Devisen	Kurs	%

Rohstoffe	Kurs	%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)

Aktuelle News von FiercePharma